Search results
Results from the WOW.Com Content Network
Memorial Sloan Kettering Cancer Center (MSK or MSKCC) is a cancer treatment and research institution in Manhattan in New York City. MSKCC is one of 72 National Cancer Institute–designated Comprehensive Cancer Centers. [3] [4] Its main campus is located at 1275 York Avenue between 67th and 68th Streets in Manhattan.
Pages in category "Memorial Sloan Kettering Cancer Center physicians" The following 15 pages are in this category, out of 15 total. This list may not reflect recent changes .
Thomas J. Kelly is an American cancer researcher whose work focuses on the molecular mechanisms of DNA replication.Kelly is director of the Sloan-Kettering Institute, [4] [5] the basic research arm of the Memorial Sloan-Kettering Cancer Center.
Founded as New York Cancer Hospital at 455 Central Park West in 1884, renamed General Memorial Hospital for the Treatment of Cancer and Allied Diseases in 1899, renamed Memorial Hospital for the Treatment of Cancer and Allied Diseases in 1916, moved to its present location in 1939, renamed Memorial Sloan Kettering Cancer Center in 1960. [35]
In December 2017, she was named Chair of the Department of Neurosurgery at Memorial Sloan Kettering Cancer Center, succeeding to Philip Gutin, MD. [3] [4] Viviane Tabar is also the founding Director of the Multidisciplinary Pituitary and Skull Base Tumor Center at Memorial Sloan Kettering Cancer Center. [5]
Joan Massagué (born April 30, 1953), is a Spanish biologist [1] and the current director of the Sloan Kettering Institute at Memorial Sloan Kettering Cancer Center.He is also an internationally recognized leader in the study of both cancer metastasis and growth factors that regulate cell behavior, as well as a professor at the Weill Cornell Graduate School of Medical Sciences.
[7] [8] [9] In 2017, Drebin moved to Memorial Sloan Kettering to become Department of Surgery Chair. [1] In addition to his responsibilities as chair, he provides surgical treatments for patients with pancreatic, gallbladder, bile duct, liver, and stomach cancers. His research focuses on the development of new targeted therapies. [1]
Robert E. Wittes was Physician-in-Chief of Memorial Sloan-Kettering Cancer Center, from 2002 until December 31, 2012.Prior to his appointment at MSKCC, he was Deputy Director for Extramural Sciences and Director of the Division of Cancer Treatment and Diagnosis at the National Cancer Institute, where he oversaw NCI's extramural clinical and basic research programs, including the evaluation of ...